Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine

Detalles Bibliográficos
Autores principales: Morlidge, Clare, El-Kateb, Sally, Jeevaratnam, Praveen, Thompson, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191285/
https://www.ncbi.nlm.nih.gov/pubmed/34119512
http://dx.doi.org/10.1016/j.kint.2021.06.005
_version_ 1783705847802626048
author Morlidge, Clare
El-Kateb, Sally
Jeevaratnam, Praveen
Thompson, Barbara
author_facet Morlidge, Clare
El-Kateb, Sally
Jeevaratnam, Praveen
Thompson, Barbara
author_sort Morlidge, Clare
collection PubMed
description
format Online
Article
Text
id pubmed-8191285
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-81912852021-06-11 Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine Morlidge, Clare El-Kateb, Sally Jeevaratnam, Praveen Thompson, Barbara Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-08 2021-06-10 /pmc/articles/PMC8191285/ /pubmed/34119512 http://dx.doi.org/10.1016/j.kint.2021.06.005 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Morlidge, Clare
El-Kateb, Sally
Jeevaratnam, Praveen
Thompson, Barbara
Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
title Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
title_full Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
title_fullStr Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
title_full_unstemmed Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
title_short Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
title_sort relapse of minimal change disease following the astrazeneca covid-19 vaccine
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191285/
https://www.ncbi.nlm.nih.gov/pubmed/34119512
http://dx.doi.org/10.1016/j.kint.2021.06.005
work_keys_str_mv AT morlidgeclare relapseofminimalchangediseasefollowingtheastrazenecacovid19vaccine
AT elkatebsally relapseofminimalchangediseasefollowingtheastrazenecacovid19vaccine
AT jeevaratnampraveen relapseofminimalchangediseasefollowingtheastrazenecacovid19vaccine
AT thompsonbarbara relapseofminimalchangediseasefollowingtheastrazenecacovid19vaccine

Ejemplares similares